X. Rosa Ma,Stephanie D. Conley,Michael Kosicki,Danila Bredikhin,Ran Cui,Steven Tran,Maya U. Sheth,Wei-Lin Qiu,Sijie Chen,Soumya Kundu,Helen Y. Kang,Dulguun Amgalan,Chad J. Munger,Lauren Duan,Katherine Dang,Oriane Matthys Rubio,Shinwan Kany,Siavash Zamirpour,John DePaolo,Arun Padmanabhan,Birth Defects Research Laboratory,Jeffrey Olgin,Scott Damrauer,Robin Andersson,Mingxia Gu,James R. Priest,Thomas Quertermous,Xiaojie Qiu,Marlene Rabinovitch,Axel Visel,Len Pennacchio,Anshul Kundaje,Ian A. Glass,Casey A. Gifford,James P. Pirruccello,William R. Goodyer,Jesse M. Engreitz

Abstract:Congenital heart defects (CHD) arise in part due to inherited genetic variants that alter genes and noncoding regulatory elements in the human genome. These variants are thought to act during fetal development to influence the formation of different heart structures. However, identifying the genes, pathways, and cell types that mediate these effects has been challenging due to the immense diversity of cell types involved in heart development as well as the superimposed complexities of interpreting noncoding sequences. As such, understanding the molecular functions of both noncoding and coding variants remains paramount to our fundamental understanding of cardiac development and CHD. Here, we created a gene regulation map of the healthy human fetal heart across developmental time, and applied it to interpret the functions of variants associated with CHD and quantitative cardiac traits. We collected single-cell multiomic data from 734,000 single cells sampled from 41 fetal hearts spanning post-conception weeks 6 to 22, enabling the construction of gene regulation maps in 90 cardiac cell types and states, including rare populations of cardiac conduction cells. Through an unbiased analysis of all 90 cell types, we find that both rare coding variants associated with CHD and common noncoding variants associated with valve traits converge to affect valvular interstitial cells (VICs). VICs are enriched for high expression of known CHD genes previously identified through mapping of rare coding variants. Eight CHD genes, as well as other genes in similar molecular pathways, are linked to common noncoding variants associated with other valve diseases or traits via enhancers in VICs. In addition, certain common noncoding variants impact enhancers with activities highly specific to particular subanatomic structures in the heart, illuminating how such variants can impact specific aspects of heart structure and function. Together, these results implicate new enhancers, genes, and cell types in the genetic etiology of CHD, identify molecular convergence of common noncoding and rare coding variants on VICs, and suggest a more expansive view of the cell types instrumental in genetic risk for CHD, beyond the working cardiomyocyte. This regulatory map of the human fetal heart will provide a foundational resource for understanding cardiac development, interpreting genetic variants associated with heart disease, and discovering targets for cell-type specific therapies.

Abstract 11332: Integration of Protein Interactome Networks with Congenital Heart Disease Variants Reveals Candidate Disease Genes

Transcription factor protein interactomes reveal genetic determinants in heart disease

Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis

Molecular convergence of risk variants for congenital heart defects leveraging a regulatory map of the human fetal heart

Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease

Integrative single-cell analysis of cardiogenesis identifies developmental trajectories and non-coding mutations in congenital heart disease

Computational analysis of congenital heart disease associated SNPs: Unveiling their impact on the gene regulatory system

Multiple gene variations contributed to congenital heart disease via GATA family transcriptional regulation

Prevalence and Spectrum of GATA5 Mutations Associated with Congenital Heart Disease.

Extensive Identification of Genes Involved in Congenital and Structural Heart Disorders and Cardiomyopathy

Identification of Dysfunctional Modules and Disease Genes in Congenital Heart Disease by a Network-Based Approach

Abstract P331: Upregulated TBX1 by Genetic Variants Are Associated with Human Congenital Heart Disease

Integrated multiomic characterization of congenital heart disease

Functional dissection of human cardiac enhancers and noncoding de novo variants in congenital heart disease

Functional Analysis of Rare Variants of GATA4 Identified in Chinese Patients with Congenital Heart Defect

Systems Analysis of de novo Mutations in Congenital Heart Diseases Identified a Molecular Network in Hypoplastic Left Heart Syndrome

Chromatin regulators in the TBX1 network confer risk for conotruncal heart defects in 22q11.2DS

A Screening Approach to Identify Clinically Actionable Variants Causing Congenital Heart Disease in Exome Data

Identification of Functional Mutations in GATA4 in Patients with Congenital Heart Disease

Progresses in Genetic Testing in Congenital Heart Disease

The Interaction Analysis of SNP Variants and DNA Methylation Identifies Novel Methylated Pathogenesis Genes in Congenital Heart Diseases